Journals / Retina-Vitreus / 2021 / Cilt: 30 - Sayı: 2

Intralenticular Dexamethasone: A Case Report

Pages
201–203
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the sixth month, the patient had uncomplicated cataract surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:examethasone implant is frequently used for macular edema in diabetic retinopathy.
📊
Key Findings & Data:We are reporting a case of a 56 year-old-woman patient with macular edema secondary to diabetes mellitus.
💡
Conclusion & Impact:In the sixth month, the patient had uncomplicated cataract surgery.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

examethasone implant is frequently used for macular edema in diabetic retinopathy. It has long-term efficiency; however some problems may be encountered during application. We are reporting a case of a 56 year-old-woman patient with macular edema secondary to diabetes mellitus. A dexamethasone implant was inadvertently injected into the crystalline lens. The patient was followed without the surgical intervention of the implant for six months. In the follow-up time, visual acuity increased, and macular edema was decreased significantly. In the sixth month, the patient had uncomplicated cataract surgery.

🔖

Cite This Article

İNAN, P., ÇİLOĞLU, E. (2022). Intralenticular Dexamethasone: A Case Report. Retina-Vitreus, Cilt: 30 - Sayı: 2, 201–203. https://ajindex.com/articles/589148

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Munteanu M, Rosca C. Repositioning and follow-up of intralenticular dexamethasone implant. J Cataract Refract Surg. 2013; 39: 1271-4
  2. Regan K, Blake CR, Lukowski ZL, et al. Intralenticular Ozurdex- One Year Later. Case Rep Ophthalmol. 2017; 8: 590-94
  3. Poornachandra B, Kumar VBM, Jayadev C, et al. Immortal Ozurdex: a 10-month follow-up of an intralenticular implant. Indian J Ophthalmol 2017;65: 255-7
  4. Coca-Robinot J, Casco-Silva B, Armad Maresca F, et al. Accidental injection of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens. Eur J Ophthalmol 2014; 24: 633-6
  5. Fasce F, Battaglia PM, Knutsson KA, et al. Accidental injection of dexamethasone intravitreal implant in the crystalline lens. Acta Ophthalmol 2014; 92: 330-1
  6. Sekeroglu MA, Anayol MA, Koc F, et al. Intralenticular sustained-release dexamethasone implant is it still effective on macular edema? Case Rep Ophthalmol 2016; 7: 85-9
  7. Chhabra R, Kopsida K, Mahmood S. Accidental insertion of dexamethasone implant into the crystalline lens-12 month follow-up. Eye 2014; 28: 624-5
  8. Abdolrahimzadeh S, Plateroti P, Scarinci F, et al. Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular edema in central retinal vein occlusion. Acta Ophthalmol 2016; 94: 810-1
  9. Clemente-Tomas R, Hernandez-Perez D, Neira-Ibanez P, et al. Intracrystalline Ozurdex: therapeutic effect maintained for 18 months. Int Ophthalmol 2017; 1-5
  10. Baskan B, Cicek A, Gulhan A, et al. Ozurdex completely located inside a crystallized lens. Results of 14 months. Am J Ophthalmol Case Reports 2016; 4: 38-40
  11. Chalioulias K, Muqit MMK. Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant. Eye 2014; 28: 1523-4
  12. Kaldırım H, Yazgan S, Atalay K, et al. Intravitreal Dexamethasone Implant in Patients With Different Morphological Diabetic Macular Edema Having Insuf ficent Response to Ranibizumab. Retina 2018;38:986-92
  13. Lazic R, Lukic M, Boras I, et al. Treatment of antivascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant. Retina 2014;34: 719-24
  14. Valverde-Megias A, Hernandez-Ruiz S, Cifuentes-Canorea P, et al. Intralenticular Ozurdex implant:What to do and how. J Fr Ophthalmol 2018; 41: 149-50.